MITO 35a
MITO 35a: a multicenter, prospective, single arm trial of Olaparib maintenance therapy in newly diagnosed BRCA wild-type advanced ovarian, primitive peritoneal, and fallopian tube cancer.
Centro Coordinatore: Istituto Nazionale Tumori Fondazione G. Pascale
Principal Investigator: Sandro Pignata
Sub Investigator: -
Study Coordinator: Clorinda Schettino, Francesco Perrone
Raccolta dati ancora in corso
Tipologia Studio
Prospettico
Patologie
Ovaio